AMENDMENTS TO PREVIOUS LISTS.
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 880
- Publication type:
- Article
Works matching IS 10109609 AND DT 2022 AND VI 36 AND IP 3
Results: 8
1
2
RECOMMENDED International Nonproprietary Names: List 88 -- COVID-19 (special edition).
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 877
- Publication type:
- Article
3
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 695
- Publication type:
- Article
4
WHO /UNFPA FEMALE CONDOM GENERIC SPECIFICATION.
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 625
- Publication type:
- Article
5
TEST FOR 1-NITROSO-4-METHYL PIPERAZINE (MeNP) IN RIFAMPICIN ACTIVE PHARMACEUTICAL INGREDIENT OR RIFAMPICIN TABLETS BY HPLC-MS/MS.
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 620
- Publication type:
- Article
6
RIFAMPICIN (RIFAMPICINUM).
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 614
- Publication type:
- Article
7
Summary of the 56<sup>th</sup> Expert Committee on Specifications for Pharmaceutical Preparations (ECSPP) Meeting.
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 609
- Publication type:
- Article
8
WORLD HEALTH ORGANIZATION External Quality Assurance Assessment Scheme Phase 10.
- Published in:
- WHO Drug Information, 2022, v. 36, n. 3, p. 595
- By:
- Publication type:
- Article